Patent ID: 6468790
Filing Date: 2002-10-22
Classification: C07K,C12N,C12Q

Abstract:
An isolated nucleic acid molecule selected from the group consisting of:a. a polynucleotide comprising SEQ ID NO:28, b. a polynucleotide comprising the full-length complement of SEQ ID NO:28, c. a polynucleotide consisting of at least 11 contiguous nucleotides of the complement of SEQ ID NO:28, wherein said polynucleotide is a probe for the identification of SEQ ID NO:28, and d. a polynucleotide comprising a sequence which is at least 95% identical to the full length of SEQ ID NO:28, wherein said polynucleotide has the same differential expression profile in metastatic relative to non-metastatic cancer cells as SEQ ID NO:28.